Immunogenicity Risk Assessment for Nucleic Acid Therapeutics
Date: October 1, 2026 Time: 11-12pm EDT / 5-6pm CEST Register Here Title: Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies Description: Nucleic acid therapeutics require new immunogenicity evaluation frameworks, as the safety and ...
Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 6
Date: September 17, 2026 Time: 11-12pm EDT / 5-6pm CEST Register Here Title: Streamlining Exon-Skipping Antisense Oligonucleotide Therapy Development Via a High-Throughput Approach Description: Disease-modifying therapies are available for <5% of the >7000 described rare genetic diseases (RGDs). Antisense oligonucleotides (ASOs) represent ...
